Amarin Corp Plc (AMRN)

[heysfguy]

I suggest a Time Out for all the Chicken Littles on this board. The most recent wake of "bad news" (such as it is) has almost everyone sniping at each other. "management needs to go", "we need to sue FDA" "delisting is imminent", arrrrgh!

The company has plenty of cash on hand to be operational well into next year and likely well into 2016/17, as well, if scripts continue to increase meaningfully. And with KOWA helping to sell, I expect scripts to increase at a higher clip sometime in the 4th Quarter.

Management obviously has a number of options to consider as to current regulatory processes, as well as patent protection, etc., but my guess is they won't be relying on us to guide them. They are experts, we aren't.

Please, let's get away from anxiety-based assumptions, scenarios, guessing games, etc., and try to post something insightful next time.

If you all can't wait 2-4 weeks to see what steps management takes next, then you obviously don't have the stomachs to be investing in biotech. Take a couple of breaths and lets get back to some sanity here.